English

INTERIM REPORT JANUARY-SEPTEMBER 2007

Report this content

• Group revenues from sales of goods and royalties amounted to 981.7 (972.2) MSEK during the period.

• Growth within the Esthetics product area was 18 percent and revenues amounted to 800.4 (680.3) MSEK.

• Operating income amounted to 381.2 (259.2) MSEK and the operating margin was 39 (29) percent.

• Income after tax amounted to 329.1 (186.7) MSEK.

• Earnings per share after full dilution were 3.31 (1.88) SEK.

• In September Q-Med obtained sales approval for MACROLANETM VRF in Europe.

July – September
• Group revenues from sales of goods and royalties amounted to 316.7 (286.0) MSEK during the third quarter and operating income amounted to 63.0 (46.3) MSEK.

• Income after tax amounted to 45.1 (35.3) MSEK during the third quarter.

Documents & Links